These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37767876)

  • 1. Development, optimization, and scale-up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus-1.
    Shen CF; Burney E; Gilbert R; Elahi SM; Parato K; Loignon M
    Biotechnol J; 2024 Jan; 19(1):e2300244. PubMed ID: 37767876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R
    Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process intensification strategies toward cell culture-based high-yield production of a fusogenic oncolytic virus.
    Göbel S; Jaén KE; Dorn M; Neumeyer V; Jordan I; Sandig V; Reichl U; Altomonte J; Genzel Y
    Biotechnol Bioeng; 2023 Sep; 120(9):2639-2657. PubMed ID: 36779302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures.
    Göbel S; Kortum F; Chavez KJ; Jordan I; Sandig V; Reichl U; Altomonte J; Genzel Y
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):4945-4961. PubMed ID: 35767011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
    Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G
    J Virol; 2017 May; 91(10):. PubMed ID: 28250120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an HSV-1 production process involving serum-reduced culturing and bead-to-bead transfer.
    Wang H; Hu X; Zhang M; Yang L; Xu Y; Gu X; Jiang J; Hu W
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):383. PubMed ID: 38896301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
    Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
    Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.
    Petrovic B; Leoni V; Gatta V; Zaghini A; Vannini A; Campadelli-Fiume G
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density.
    Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z
    Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
    Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus.
    Nguyen HM; Sah N; Humphrey MRM; Rabkin SD; Saha D
    J Vis Exp; 2021 May; (171):. PubMed ID: 34057449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production Process Development of Pseudorabies Virus Vaccine by Using a Novel Scale-Down Model of a Fixed-Bed Bioreactor.
    Nie J; Sun Y; Peng F; Li X; Yang Y; Liu X; Li Y; Liu C; Bai Z
    J Pharm Sci; 2020 Feb; 109(2):959-965. PubMed ID: 31604085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures.
    Fulber JPC; Farnós O; Kiesslich S; Yang Z; Dash S; Susta L; Wootton SK; Kamen AA
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus.
    Göbel S; Jaén KE; Fernandes RP; Reiter M; Altomonte J; Reichl U; Genzel Y
    Biotechnol Bioeng; 2023 Nov; 120(11):3335-3346. PubMed ID: 37584190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells.
    Nikolay A; Castilho LR; Reichl U; Genzel Y
    Vaccine; 2018 May; 36(22):3140-3145. PubMed ID: 28343780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.